BMO MSCI GENOMIC INNOVATION INDEX ETF - CAD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18 CAD | -0.06% |
|
-0.28% | -.--% |
Investment objective
BMO MSCI Genomic Innovation Index ETF has been designed to replicate, to the extent possible, the performance of the MSCI ACWI IMI Genomic Innovation Index, net of expenses. The Fund captures this mega trend by investing in stocks that have high exposure to innovative genomic companies. The Fund invests in and holds the Constituent Securities of the Index in the same proportion as they are reflected in the Index.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 573.6 USD | +0.33% | +5.29% | +8.07% | 5.37% | ||
| 65.42 USD | +0.23% | -2.01% | -19.24% | 5.23% | ||
| 397.5 USD | -0.06% | +0.81% | -2.31% | 5.20% | ||
| 107.5 USD | +0.63% | +0.23% | -2.31% | 5.19% | ||
| 44.85 USD | +0.34% | -8.34% | -12.59% | 4.99% | ||
| 108 USD | +1.69% | +6.47% | +8.57% | 4.69% | ||
| 221 CHF | +1.01% | -0.50% | -9.61% | 4.67% | ||
| 527.8 CHF | +2.72% | +4.97% | +49.22% | 4.53% | ||
| 122.3 USD | +1.02% | +4.13% | -12.18% | 4.11% | ||
| 143.3 USD | -0.28% | -0.76% | -25.13% | 4.04% | ||
More news
In partnership with
Description
| CA05591N1033 | |
|---|---|
| Total Expense Ratio | 0.45% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MSCI ACWI IMI Genomic Innovation Index - CAD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
25/01/2021
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 30/10/2023 )
| AuM (EUR) | 2 M€ |
|---|---|
| AuM 1M | 3 M€ |
| AuM 3 months | 3 M€ |
| AuM 6 months | 3 M€ |
| AuM 12 months | 3 M€ |
- Stock Market
- ETF
- ZGEN ETF
